GC Genome Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	176,908	161,298	-	-	-	-
Enterprise Value	140,809	124,035	-	-	-	-
Last Close Price	7480.00	6820.00	-	-	-	-
PE Ratio	40.43	39.88	-	-	-	-
PS Ratio	5.61	5.12	-	-	-	-
PB Ratio	2.26	2.06	-	-	-	-
P/TBV Ratio	2.28	2.08	-	-	-	-
P/FCF Ratio	179.50	163.66	-	-	-	-
P/OCF Ratio	136.40	124.37	-	-	-	-
EV/Sales Ratio	4.47	3.93	-	-	-	-
EV/EBITDA Ratio	30.24	30.23	-	-	-	-
EV/EBIT Ratio	78.70	100.38	-	-	-	-
EV/FCF Ratio	142.87	125.85	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.14	0.47	0.40	0.74
Debt / EBITDA Ratio	0.98	0.98	2.35	3.18	-	-
Debt / FCF Ratio	4.08	4.08	94.54	-	-	-
Net Debt / Equity Ratio	-0.46	-0.46	-0.06	0.13	-0.26	-0.61
Net Debt / EBITDA Ratio	-8.80	-8.80	-0.93	0.84	16.39	224.25
Net Debt / FCF Ratio	-36.63	-36.63	-37.60	-0.77	1.25	3.96
Asset Turnover	0.50	0.50	0.62	0.60	0.53	0.44
Inventory Turnover	10.51	10.51	11.96	11.56	14.85	-
Quick Ratio	17.67	17.67	3.74	1.00	2.13	6.26
Current Ratio	18.59	18.59	4.27	1.12	2.32	6.42
Return on Equity (ROE)	7.26%	7.26%	-4.32%	-2.13%	-16.52%	1.56%
Return on Assets (ROA)	1.23%	1.23%	-1.85%	0.22%	-4.43%	-3.13%
Return on Invested Capital (ROIC)	3.01%	3.28%	-4.15%	0.67%	-24.07%	-34.01%
Return on Capital Employed (ROCE)	1.50%	1.50%	-3.30%	0.50%	-8.40%	-5.60%
Earnings Yield	2.29%	2.51%	-	-	-	-
FCF Yield	0.56%	0.61%	-	-	-	-
Buyback Yield / Dilution	-20.01%	-20.01%	0.66%	-13.53%	-0.97%	10.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.